Page 34 - Read Online

Page 8 of 10 Watanabe. Vessel Plus 2020;4:4 I http://dx.doi.org/10.20517/2574-1209.2019.27

Mol Biol 1995;29:1015-26.
16. Viktorova J, Rehorova K, Musilova L, Suman J, Lovecka P, et al. New findings in potential applications of tobacco osmotin. Protein Expr
Purif 2017;129:84-93.
17. Yun DJ, Ibeas JI, Lee H, Coca MA, Narasimhan ML, et al. Osmotin, a plant antifungal protein, subverts signal transduction to enhance
fungal cell susceptibility. Mol Cell 1998;1:807-17.
18. Narasimhan ML, Coca MA, Jin J, Yamauchi T, Ito Y, et al. Osmotin is a homolog of mammalian adiponectin and controls apoptosis in
yeast through a homolog of mammalian adiponectin receptor. Mol Cell 2005;17:171-80.
19. Ohashi K, Ouchi N, Matsuzawa Y. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 2012;94:2137-42.
20. Sargolzaei J, Chamani E, Kazemi T, Fallah S, Soori H. The role of adiponectin and adipolin as anti-inflammatory adipokines in the
formation of macrophage foam cells and their association with cardiovascular diseases. Clin Biochem 2018;54:1-10.
21. Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation
of metabolic and cardiovascular diseases. Int J Obes (Lond) 2008;32:S13-8.
22. Miele M, Costantini S, Colonna G. Structural and functional similarities between osmotin from Nicotiana tabacum seeds and human
adiponectin. PLoS One 2011;6:e16690.
23. Aouida M, Kim K, Shaikh AR, Pardo JM, Eppinger J, et al. A Saccharomyces cerevisiae assay system to investigate ligand/AdipoR1
interactions that lead to cellular signaling. PLoS One 2013;8:e65454.
24. Badshah H, Ali T, Kim MO. Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling
pathway. Sci Rep 2016;6:24493.
25. Naseer MI, Ullah I, Narasimhan ML, Lee HY, Bressan RA, et al. Neuroprotective effect of osmotin against ethanol-induced apoptotic
neurodegeneration in the developing rat brain. Cell Death Dis 2014;5:e1150.
26. de Winther MPJ, Kanters E, Kraal G, Hofker MH. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol
2005;25:904-14.
27. Muslin AJ. MAPK signaling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond)
2008;115:203-18.
28. Motoshima H, Goldstein BJ, Igata M, Araki E. AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer.
J Physiol 2006;574:63-71.
29. Fang H, Judd R. Adiponectin regulation and function. Compr Physiol 2018;8:1031-63.
30. Esfahani M, Shabab N, Saidijam M. AdipoRon may be benefit for atherosclerosis prevention. Iran J Basic Med Sci 2017;20:107-9.
31. Trivedi VR, Chorawala MR, Shah GB. Antiatherosclerotic activity of osmotin, an adiponectin agonist in atherogenic diet induced
hypertriglyceridemia and hypercholesterolemia in Wistar rats. Adv Res Pharmaceuticals Biol 2012;2:196-207.
32. Trivedi VR, Chorawala MR, Shah GB. Osmotin: a new adiponectin agonist, in type-II diabetes and obesity. Int J Pharm Sci Rev Res
2012;16:70-4.
33. Jo MG, Kim MW, Jo MH, Bin Abid N, Kim MO. Adiponectin homolog osmotin, a potential ant-obesity compound, suppresses abdominal
fat accumulation in C57BL/6 mice on high-fat diet and in 3T3-L1 adipocytes. Int J Obes (Lond) 2019;43:2422-33.
34. Zhao W, Wu C, Li S, Chen X. Adiponectin protects palmitic acid induced endothelial inflammation and insulin resistance via regulating
ROS/IKK pathways. Cytokine 2016;88:167-76.
35. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma
protein adiponectin. Circulation 1999;100:2473-6.
36. Lu Y, Gao X, Wang R, Sun J, Guo B, et al. Adiponectin inhibits proliferation of vascular endothelial cells induced by Ox-LDL by
promoting dephosphorylation of Caveolin-1 and depolymerization of eNOS and up-regulating release of NO. Int Immunopharmacol
2019;73:424-34.
37. Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, et al. Adiponectin promotes macrophage polarization towards an anti-inflammatory
phenotype. J Biol Chem 2010;285:6153-60.
38. Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME. Adiponectin differentially regulates cytokines in porcine
macrophages. Biochem Biophys Res Commun 2004;316:924-9.
39. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid
accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057-63.
40. Furukawa K, Hori M, Ouchi N, Kihara S, Funahashi T, et al. Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1
in cultured human monocyte-derived macrophages. Biochem Biophys Res Commun 2004;317:831-6.
41. Tsubakio-Yamamoto K, Matsuura F, Koseki M, Oku H, Sandoval JC, et al. Adiponectin prevents atherosclerosis by increasing cholesterol
efflux from macrophages. Biochem Biophys Res Commun 2008;375:390-4.
42. Motobayashi Y, Izawa-Ishizawa Y, Ishizawa K, Orino S, Yamaguchi K, et al. Adiponectin inhibits insulin-like growth factor-1-induced
cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells.
Hypertens Res 2009;32:188-93.
43. Chen X, Yuan Y, Wang Q, Xie F, Xia D, et al. Post-translational modulation of adiponectin affects lipid accumulation, proliferation and
migration of vascular smooth muscle cells. Cell Physiol Biochem 2017;43:172-81.
44. Wang YT, Chen J, Li X, Umetani M, Chen Y, et al. Contribution of transcription factor EB to adipoRon-induced inhibition of arterial
smooth muscle cell proliferation and migration. Am J Physiol Cell Physiol 2019;317:C1034-47.
45. Lu Y, Ma Y, Wang R, Sun J, Guo B, et al. Adiponectin inhibits vascular smooth muscle cell calcification induced by beta-
glycerophosphate through JAK2/STAT3 signaling pathway. J Biosci 2019;44:86.